New tool aims to simplify tough choices for lung cancer patients

NCT ID NCT05191485

Recruiting now Knowledge-focused Sponsor: Sichuan Cancer Hospital and Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to create a decision aid for people with lung adenocarcinoma who need to decide whether to have molecular testing after surgery. Researchers will interview patients, family members, and doctors to understand what information is needed. The final tool will be tested with 190 participants to see if it helps patients and doctors make shared decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could provide a tool to help patients and doctors make more informed decisions about molecular testing after lung cancer surgery.
What could go wrong: This is an early-stage study focused on developing and testing a decision aid, not on treatment outcomes. The tool may not change patient decisions or improve health results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Adenocarcinoma of Lung lung adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG ADENOCARCINOMA SURGERY

Contacts and locations

Locations

Sichuan Cancer Hospital & Institute
RECRUITING

Chengdu, Sichuan, 610041, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.